Global Addiction Disorders Drugs Market
Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Global Addiction Disorders Drugs Market by Drug Type (Alcohol, Marijuana, Prescription & Over-the-Counter Medications), Treatment (Counseling & Behavioral Therapies, Detoxification, Medications), End-user - Cumulative Impact of High Inflation - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering.
The Global Addiction Disorders Drugs Market was estimated to be worth USD 23.95 billion in 2022, and is expected to reach USD 25.46 billion in 2023. It is expected to rise at a CAGR of 6.44% to reach USD 39.47 billion by 2030. The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the market, including:
-
Accord Healthcare Limited
-
Alkermes PLC
-
Aurobindo Pharma Limited
-
BioCorRx Inc.
-
Cipla Limited
-
Consern Pharma Limited
-
GlaxoSmithKline PLC
-
Insys Therapeutics
-
Mallinckrodt Pharmaceuticals
-
Medtronic PLC
-
Novartis AG
-
Perrigo Company PLC
-
Pfizer, Inc.
-
Psychemedics Corporation
-
Purdue Pharma L.P.
-
Reckitt Benckiser Pharmaceuticals, Inc.
-
Sun Pharmaceutical Industries Limited
-
Takeda Pharmaceutical Company Ltd.
-
Teva Pharmaceutical Industries, Ltd.
The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and high inflation is expected to have significant long-term effects on the market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.
Market Segmentation & Coverage
This research report categorizes the market in order to forecast the revenues and analyze trends in each of following sub-markets:
-
Based on Drug Type, market is studied across Alcohol, Marijuana, Prescription & Over-the-Counter Medications, Synthetic Cannabinoids, and Tobacco/Nicotine & Vaping. The Tobacco/Nicotine & Vaping is projected to witness significant market share during forecast period.
-
Based on Treatment, market is studied across Counseling & Behavioral Therapies, Detoxification, Medications, Rehabilitation Programs, and Self-Help Groups. The Rehabilitation Programs is projected to witness significant market share during forecast period.
-
Based on End-user, market is studied across Hospital & Clinics and Residential Treatment Centers. The Residential Treatment Centers is projected to witness significant market share during forecast period.
-
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.